The combination human 13 gene mutation Detection kit (reversible terminal termination sequencing) complements the clinical trial
Ontology highlight
ABSTRACT: Interventions: Gold Standard:Comparison methods :(1) comparison of similar kits;(2) Sequencing method;Index test:Human 13 gene mutation Combination Detection Kit (reversible terminal termination sequencing method)
Primary outcome(s): Lung and gastrointestinal tumor genes
Study Design: Sequential
DISEASE(S): Non-small Cell Lung Cancer (nsclc), Colorectal Cancer (crc) , Gastrointestinal Stromal Tumor (gist)
PROVIDER: 2696826 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA